Since NT-proBNP is an established prognostic risk factor for HF patients, we selected the subgroup of patients that in our cohort were presenting a NT-proBNP ≥ 1000 pg/mL at admission (n = 35). The gene discussed is NPPB; the disease is hydrops fetalis.